Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (11276)	8/17/1999 12:55:00 AM
From: John Romeo	Read Replies (3) \| Respond to of 17367

Question on adding Morbidity endpoint. There are so many types of morbidity in human illness. I don't know those of Menningo., brain damage,neuropathy,sepsis and others? These leave alot more blanks to fill,am I right? With use of Mortality endpoint, dead or alive, this makes adding up all the data points more complex,taxing,longer and open for interpretation. Doesn't adding Morbidity lengthen the process? If it did could it be a part of the reason in delaying the release of full clinical results?